FDA Warns Court Not To Side With Sandoz In Drug Challenge
The U.S. Food and Drug Administration warned the D.C. Circuit on Monday that the court risked upending the way the agency awards exclusivity to drugs and provides incentives to create new ones...To view the full article, register now.
Already a subscriber? Click here to view full article